NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.97
+0.45 (1.27%)
At close: Dec 4, 2025, 4:00 PM EST
35.85
-0.12 (-0.33%)
After-hours: Dec 4, 2025, 5:41 PM EST
NAMS Market Cap
NAMS has a market cap or net worth of $4.07 billion as of December 4, 2025. Its market cap has increased by 76.71% in one year.
Market Cap
4.07B
Enterprise Value
3.31B
1-Year Change
76.71%
Ranking
Category
Stock Price
$35.97
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.07B, an increase of 2,531.97%. That is a compound annual growth rate of 97.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 4.03B | 46.39% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 938.51B |
| Johnson & Johnson | 492.39B |
| AbbVie | 395.56B |
| UnitedHealth Group | 293.63B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.24B |
| Abbott Laboratories | 218.65B |